Naik, V., Darandale, A. and Pal, P. (2026) “Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: ‘Cardiovascular and Renal Benefits and Risks’”, Cardiovascular Disease Prevention and Control, 1(1), pp. 29–38. doi:10.64229/v3v43h95.